Arbor Investment Advisors’s AbbVie ABBV Stock Holding History

Arbor Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$593K	Buy	2,358 +437	+23%	+$94K	0.07%	74
2026 Q1	$418K	Buy	1,921 +475	+33%	+$105K	0.05%	72
2025 Q4	$330K	Hold	1,446	–	–	0.04%	79
2025 Q3	$335K	Sell	1,446 -837	-37%	-$170K	0.04%	92
2025 Q2	$424K	Hold	2,283	–	–	0.05%	65
2025 Q1	$478K	Sell	2,283 -170	-7%	-$33K	0.07%	58
2024 Q4	$436K	Sell	2,453 -22	-0.9%	-$4.04K	0.06%	61
2024 Q3	$489K	Hold	2,475	–	–	0.06%	67
2024 Q2	$425K	Hold	2,475	–	–	0.06%	57
2024 Q1	$451K	Buy	2,475 +65	+3%	+$11.2K	0.07%	63
2023 Q4	$374K	Sell	2,410 -351	-13%	-$51.2K	0.06%	62
2023 Q3	$412K	Hold	2,761	–	–	0.07%	59
2023 Q2	$372K	Hold	2,761	–	–	0.07%	66
2023 Q1	$440K	Sell	2,761 -225	-8%	-$34.4K	0.08%	59
2022 Q4	$483K	Buy	2,986 +698	+31%	+$107K	0.1%	57
2022 Q3	$307K	Buy	2,288 +139	+6%	+$19.9K	0.07%	51
2022 Q2	$329K	Hold	2,149	–	–	0.07%	69
2022 Q1	$348K	Buy	+2,149	New	+$312K	0.07%	76

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Arbor Investment Advisors's ABBV Position: Q2 2026 in Review

Arbor Investment Advisors increased its AbbVie (ABBV) stake by 23% in Q2 2026, buying an estimated $94K and bringing the position to 2,358 shares worth $593K. The position accounts for 0.07% of the portfolio, ranked #74.

Arbor Investment Advisors first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Arbor Investment Advisors held 2,358 shares of AbbVie worth $593K as of Q2 2026.
Arbor Investment Advisors bought 437 AbbVie shares in Q2 2026, an estimated $94K.
AbbVie made up 0.07% of Arbor Investment Advisors's portfolio in Q2 2026, its #74 holding.
Arbor Investment Advisors first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Arbor Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.